Only a quarter of Clostridium difficile infections in one hospital system were traced to contact with a symptomatic patient.
The Scientist
Most Recent
The US National Science Advisory Board for Biosecurity explains why it recommended redacting the details of studies reporting on a highly transmissible H5N1 strain.
A public-private partnership including 13 pharmaceutical companies pledge more than $785 million to fight neglected tropical diseases.
An attempt to regrow the infamous GFAJ-1 bacteria, reported to incorporate arsenic into its DNA backbone, has failed.
The agency releases draft guidelines on unsolicited questions about off-label use, but leaves many questions about social media marketing unanswered.
Our list of the best and brightest products that 2011 had to offer the life scientist
Some Big Pharma companies are turning to the world’s automobile makers for advice on innovation and profitability.
Researchers have mapped out the DNA of what some scientists claim to be an arsenic loving bacterium.
New research suggests that a controversial class of stem cells originates in the heart and retains some ability to repair damaged tissue.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
